INTERREG EUROPE Through its cohesion policy the European Union works to reduce disparities in the levels of development, growth and quality of life in European regions. It promotes actions designed to make the European territory more innovative, more sustainable, and more inclusive. This is the EU policy agenda, called the Europe 2020 strategy. The Interreg […]
The Laboratory of Molecular Hematology, led by IDIVAL researcher Carlos Pipaón, has found while working with G418-resistant stably transfected cells, they realized the neomycin resistance gene (NeoR), which encodes the aminoglycoside-3′-phosphotransferase-IIa [APH(3′)-IIa], also confers resistance to the nucleoside analog fludarabine. Fludarabine is a cytostatic drug widely used in the treatment of hematologic and solid tumors […]
IDIVAL publishes the Innovation Support Program to chronic patient care (INNyCRON). The Program’s objective is to facilitate and promote innovation projects related with the Cantabria Chronicity Strategy. The INNyCRON call is part of the Chronicity Strategy of Cantabria in which the Ministry of Health and the Cantabrian Health Service, which are the promoters of this […]
Valdecilla brand, created in 1929, has been cited more than 100,000 times by the international biomedical literature, according to data obtained on the Web of Science database. According to these data, papers published by the authors who have in their affiliation the brand Valdecilla (exclusive brand worldwide of our Hospital) have been referenced in more […]
